Immunology · 2009 · 15 citations · 34 references
Life SciencesImmunologyInfectious DiseasesAdaptive ImmunityImmunology Of Infectious DiseasesInnate ImmunityCell-mediated ImmunityImmunodeficiency DisordersInnate Immune ActivationKiller Cell Immunoglobulin-like Receptor GeneticsNatural Killer Cell BiologyNatural Killer Cell FunctionHuman Leukocyte Antigen GenotypeInnate Immune Response VariationKiller Cell Immunoglobulin-like Receptor Gene FamilyKiller Cell Immunoglobulin-like Receptor HaplotypesKiller Cell Immunoglobulin-like Receptor-human Leukocyte Antigen InteractionsKiller-cell Immunoglobulin-like ReceptorsNatural Killer Cell DeficiencyViral Co-infection
Natural killer (NK) cells bridge the interface between innate and adaptive immunity and are implicated in the control of herpes simplex virus 2 (HSV-2) infection. In subjects infected with human immunodeficiency virus 1 (HIV-1), the critical impact of the innate immune response on disease progression has recently come into focus. Higher numbers of NK cells are associated with lower HIV-1 plasma viraemia. Individuals with the compound genotype of killer cell immunoglobulin-like receptor (KIR) 3DS1 and human leucocyte antigen (HLA)-Bw4-80I, or who have alleles of KIR3DL1 that encode proteins highly expressed on the NK cell surface, have a significant delay in disease progression. We studied the effect of HSV-2 co-infection in HIV-1-infected subjects, and show that HSV-2 co-infection results in a pan-lymphocytosis, with elevated absolute numbers of CD4(+) and CD8(+) T cells, and NK cells. The NK cells in HSV-2 co-infected subjects functioned more efficiently, with an increase in degranulation after in vitro stimulation. The number of NK cells expressing the activating receptors NKp30 and NKp46, and expressing KIR3DL1 or KIR3DS1, was inversely correlated with HIV-1 plasma viral load in subjects mono-infected with HIV-1, but not in subjects co-infected with HSV-2. This suggests that HSV-2 infection mediates changes within the NK cell population that may affect immunity in HIV-1 infection.
34
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Klas Kärre, Hans Ljunggren, Gerald E. Piontek et al. · Nature · 1986 · 2.1K citations
Life Sciences, Immunology, Oncology +12
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Maureen P. Martin, Xiaojiang Gao, Jeong-Hee Lee et al. · Nature Genetics · 2002 · 1.2K citations
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
Maureen P. Martin, Qi Ying, Xiaojiang Gao et al. · Nature Genetics · 2007 · 742 citations · Full text